This compound is a protected uridine phosphoramidite derivative used as a building block in the solid-phase synthesis of oligonucleotides. Its structure incorporates a 2'-O-(2-methoxyethyl) modification, a 5'-O-dimethoxytrityl protecting group, and a 3'-O-(diisopropylamino-2-cyanoethoxyphosphanyl) group, making it suitable for automated RNA synthesis in research and pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 163759-97-5
Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-propyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI)
RNA synthesis building block
Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
RNA synthesis phosphoramidite building block
2'-propargyl U amidite
RNA synthesis phosphoramidite building block
2'-O-Hexadecyl-U-CE-Phosphoramidite
nucleoside phosphoramidite for oligonucleotide synthesis
(R)-1-Boc-3-methylpiperazine
pharmaceutical intermediate
(S)-2,4,5-Trifluoro-N-(1,1,1-trifluoropropan-2-yl)benzamide
Pharmaceutical intermediate
2-Ethoxy-1,3-benzodioxole-5-carboxaldehyde
pharmaceutical intermediate
(S)-N-Benzyl-1-(1-naphthyl)ethylamine hydrochloride
pharmaceutical intermediate
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-(2-methoxyethoxy)oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
ZLOKLUONKGURQI-UAQIPLLRSA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC